Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMYMP) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to -$1.6 billion.

  • Bristol Myers Squibb's Other Gross PP&E Adjustments fell 2924.84% to -$1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.6 billion, marking a year-over-year decrease of 2924.84%. This contributed to the annual value of -$1.6 billion for FY2025, which is 2924.84% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Other Gross PP&E Adjustments of -$1.6 billion as of Q4 2025, which was down 2924.84% from -$1.6 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Other Gross PP&E Adjustments ranged from a high of -$840.0 million in Q2 2022 and a low of -$1.6 billion during Q3 2025
  • Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$1.2 billion (2023), whereas its average is -$1.2 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Other Gross PP&E Adjustments surged by 1650.1% in 2022, and later plummeted by 5481.31% in 2023.
  • Over the past 5 years, Bristol Myers Squibb's Other Gross PP&E Adjustments (Quarter) stood at -$919.0 million in 2021, then tumbled by 32.75% to -$1.2 billion in 2022, then fell by 13.93% to -$1.4 billion in 2023, then rose by 11.94% to -$1.2 billion in 2024, then dropped by 29.25% to -$1.6 billion in 2025.
  • Its Other Gross PP&E Adjustments stands at -$1.6 billion for Q4 2025, versus -$1.6 billion for Q3 2025 and -$1.3 billion for Q2 2025.